facebook-page-view
Advertisement

Intas Pharma files DRHP with SEBI; ChrysCapital eyes 13-14x part-exit

By Madhav A Chanchani

  • 17 Jun 2013
Premium
Intas Pharma files DRHP with SEBI; ChrysCapital eyes 13-14x part-exit

Ahmedabad-based Intas Pharmaceuticals Ltd has filed draft red-herring prospectus (DRHP) with the market regulator for an issue which will see ChrysCapital part-exit with over 13-14x returns, said sources familiar with the development. ChrysCapital has invested in Intas through two of its funds on seperate occasions, first in 2006 and then ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement